ALKS Alkermes plc logo

ALKS Alkermes plc

Healthcare
$37.31+0.00%OpenMarket Cap: $6.22B

As of 2026-05-26

Insider Statistics (Q2 2026)

Acquisitions

27

Dispositions

24

Buy/Sell Ratio

1.13

Net Shares

+99,075

Shares Acquired

198,463

Shares Disposed

99,388

Total Bought ($)

$0.00

Total Sold ($)

$4.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Fri May 22Wright Christopher IdirectorSell6,142$0.0029,155
Fri May 22Wright Christopher IdirectorSell1,475$36.9527,680
Fri May 22Wright Christopher IdirectorSell11,538$36.9811,538
Fri May 22Wright Christopher IdirectorSell5,409$0.005,409
Fri May 22Wilson Frank AndersdirectorSell6,142$0.0037,226
Fri May 22Wilson Frank AndersdirectorSell1,475$36.9535,751
Fri May 22Wilson Frank AndersdirectorSell11,538$36.9811,538
Fri May 22Wilson Frank AndersdirectorSell5,409$0.005,409
Mon May 04Gaffin David Josephofficer: EVP, CLO, Alkermes, Inc.Sell2,034$33.20231,558
Fri May 01Hopkinson Craig C.officer: EVP R&D, Chief Medical OfficerSell9,000$33.4081,389
Fri May 01Hopkinson Craig C.officer: EVP R&D, Chief Medical OfficerSell5,000$19.3490,389
Mon Apr 13Lurker NancydirectorSell3,751$0.0014,456
Mon Apr 13Lurker NancydirectorSell901$33.3613,555
Mon Apr 06Gaffin David Josephofficer: EVP, CLO, Alkermes, Inc.Sell2,034$34.57233,592
Wed Apr 01Hopkinson Craig C.officer: EVP R&D, Chief Medical OfficerSell9,000$35.5185,389